Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_assertion type Assertion NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_head.
- NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_assertion description "[We treated 32 patients with Ph1-negative chronic myeloproliferative disorders (CMD) with excessive thrombocytosis with Interferon alpha-2b (IFN alpha-2b): 26 had essential thrombocythaemia, ET (18 previously untreated, eight pretreated); one thrombocythaemia after treatment for Hodgkin's disease (HD); two thrombocythaemia associated with non-Hodgkin's lymphoma (NHL); three stage II idiopathic myelofibrosis (IM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_provenance.
- NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_assertion evidence source_evidence_literature NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_provenance.
- NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_assertion SIO_000772 2757963 NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_provenance.
- NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_assertion wasDerivedFrom befree-20140225 NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_provenance.
- NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_assertion wasGeneratedBy ECO_0000203 NP609087.RAsvNLY0wLM05Yd5ijRYFZA7dYa6UEpiaWDrETR2rVYxc130_provenance.